SCHEMBL17101017

SCHEMBL17101017

COc1ccc(S(=O)(=O)N2CCN(c3nc(Cc4cccc(Cl)c4)no3)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
LMNA P02545 4/20 0.61
MAPK1 P28482 2/20 0.61
TSHR P16473 2/20 0.61
POLB P06746 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KMT2A Q03164 2/20 0.48
PKM P14618 4/20 0.46
NPC1 O15118 1/20 0.46
PKLR P30613 1/20 0.46
RAB9A P51151 1/20 0.46
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
HSD11B1 P28845 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TP53 P04637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GBA1 P04062 1/20 0.44
PTPN11 Q06124 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17100888 0.91 L3MBTL1 (0.50) ALDH1A1LMNAMAPK1TSHRPOLB
SCHEMBL17100715 0.91 L3MBTL1 (0.50) ALDH1A1LMNAMAPK1TSHRPOLB
SCHEMBL17100660 0.89 ALDH1A1 (0.57) ALDH1A1LMNAMAPK1TSHRPOLB
SCHEMBL17100842 0.89 ALDH1A1 (0.59) ALDH1A1LMNAMAPK1TSHRPOLB
SCHEMBL17100713 0.89 PKM (0.57) ALDH1A1LMNATSHRPOLBSMN1; SMN2
SCHEMBL17100677 0.89 ALDH1A1 (0.46) ALDH1A1LMNAMAPK1TSHRPOLB
SCHEMBL17100640 0.86 LMNA (0.52) ALDH1A1LMNAMAPK1TSHRPOLB
SCHEMBL17100707 0.86 KMT2A (0.48) ALDH1A1LMNAMAPK1TSHRPOLB
SCHEMBL17100850 0.84 KMT2A (0.53) ALDH1A1LMNATSHRPOLBSMN1; SMN2
SCHEMBL17101010 0.82 PKM (0.56) ALDH1A1LMNAMAPK1TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200140400-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2020-05-07 US claimed
US-10562869-B2 Oxadiazole compounds REMYND NV (BE) 2020-02-18 US claimed
US-20170073319-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2017-03-16 US claimed
EP-3119774-A1 OXADIAZOLE COMPOUNDS reMynd NV (BE) 2017-01-25 EP claimed
WO-2015140130-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2015-09-24 WO claimed
US-20200140400-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2020-05-07 US disclosed
US-20200140400-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2020-05-07 US disclosed
US-10562869-B2 Oxadiazole compounds REMYND NV (BE) 2020-02-18 US disclosed
US-10562869-B2 Oxadiazole compounds REMYND NV (BE) 2020-02-18 US disclosed
US-20170073319-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2017-03-16 US disclosed
US-20170073319-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2017-03-16 US disclosed
US-20170073319-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2017-03-16 US disclosed
EP-3119774-A1 OXADIAZOLE COMPOUNDS reMynd NV (BE) 2017-01-25 EP disclosed
WO-2015140130-A1 OXADIAZOLE COMPOUNDS REMYND NV (BE) 2015-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10562869-B2 Oxadiazole compounds OXA1L, PSEN1, MAPT ALDH1A1 482/4885LMNA 760/4885MAPK1 1814/4885
US-20200140400-A1 OXADIAZOLE COMPOUNDS OXA1L, PSEN1, MAPT ALDH1A1 561/4885LMNA 748/4885MAPK1 1833/4885
US-20170073319-A1 OXADIAZOLE COMPOUNDS OXA1L, PSEN1, MAPT ALDH1A1 482/4885LMNA 760/4885MAPK1 1814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.